Literature DB >> 21037872

Commentary: improving breast cancer testing for patients-the secret sauce is collaboration.

M Elizabeth H Hammond.   

Abstract

Entities:  

Year:  2010        PMID： 21037872      PMCID： PMC2900871          DOI： 10.1200/JOP.777012

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  4 in total

1.  American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Authors:  M Elizabeth H Hammond; Daniel F Hayes; Antonio C Wolff; Pamela B Mangu; Sarah Temin
Journal:  J Oncol Pract       Date:  2010-06-23       Impact factor: 3.840

2.  Variable specimen handling affects hormone receptor test results in women with breast cancer: a large multihospital retrospective study.

Authors:  Flory L Nkoy; M Elizabeth H Hammond; William Rees; Tom Belnap; Braden Rowley; Steve Catmull; William Sause
Journal:  Arch Pathol Lab Med       Date:  2010-04       Impact factor: 5.534

3.  Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.

Authors:  Hazel B Nichols; Amy Trentham-Dietz; Richard R Love; John M Hampton; Pham Thi Hoang Anh; D Craig Allred; Syed K Mohsin; Polly A Newcomb
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-01       Impact factor: 4.254

Review 4.  American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Authors:  M Elizabeth H Hammond; Daniel F Hayes; Mitch Dowsett; D Craig Allred; Karen L Hagerty; Sunil Badve; Patrick L Fitzgibbons; Glenn Francis; Neil S Goldstein; Malcolm Hayes; David G Hicks; Susan Lester; Richard Love; Pamela B Mangu; Lisa McShane; Keith Miller; C Kent Osborne; Soonmyung Paik; Jane Perlmutter; Anthony Rhodes; Hironobu Sasano; Jared N Schwartz; Fred C G Sweep; Sheila Taube; Emina Emilia Torlakovic; Paul Valenstein; Giuseppe Viale; Daniel Visscher; Thomas Wheeler; R Bruce Williams; James L Wittliff; Antonio C Wolff
Journal:  J Clin Oncol       Date:  2010-04-19       Impact factor: 44.544
  4 in total
  3 in total

1.  Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.

Authors:  Pierre-Etienne Heudel; Isabelle Van Praagh-Doreau; Bernard Duvert; Isabelle Cauvin; Anne-Claire Hardy-Bessard; Jean-Philippe Jacquin; Laetitia Stefani; Lionel Vincent; Dominique Dramais; Jean-Paul Guastalla; Ellen Blanc; Aurélie Belleville; Emilie Lavergne; David Pérol
Journal:  Support Care Cancer       Date:  2018-09-07       Impact factor: 3.603

2.  Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients.

Authors:  Martin Zweifel; Beat Thürlimann; Salome Riniker; Patrik Weder; Roger von Moos; Olivia Pagani; Martin Bigler; Karin M Rothgiesser; Christiane Pilop; Hanne Hawle; Peter Brauchli; Coya Tapia; Wolfgang Schoenfeld; Cristiana Sessa
Journal:  Endocr Connect       Date:  2017-08-16       Impact factor: 3.335

3.  Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas.

Authors:  Seth B Sereff; Michael W Daniels; James L Wittliff
Journal:  J Clin Lab Anal       Date:  2019-07-29       Impact factor: 2.352
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.